CXCL8 and gastric cancer: GC-MSCs have the highest levels of the pro-angiogenic factors VEGF, MIP-2, transforming growth factor TGF-β1, IL-6, and—especially—IL-8, showing the ability of GC-MSCs to enhance GC angiogenesis—mostly by secreting the inflammatory cytokine IL-8.